Efficacy and Safety of Basiliximab with a Tacrolimus-Based Regimen in Liver Transplant Recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Basiliximab with a Tacrolimus-Based Regimen in Liver Transplant Recipients

Published:2004-09-27 Issue:6 Volume:78 Page:886-891
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Marino Ignazio R.,Doria Cataldo,Scott Victor L.,Foglieni Carlo Scotti,Lauro Augusto,Piazza Tommaso,Cintorino Davide,Gruttadauria Salvatore

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference36 articles.

1. Primer on transplantation [ed 2].;Brennan,2001

2. Options for induction immunosuppression in liver transplant recipients.;Moser;Drugs,2003

3. Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials.;Adu;BMJ,2003

4. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients.;Nashan;Lancet,1997

5. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody.;Kahan;Transplantation,1999

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extra-hepatic epithelioid hemangioendothelioma: pushing the limit with sirolimus in combination with liver transplantation;Updates in Surgery;2024-07-02

2. Indications and results of right-lobe living donor liver transplantation;Updates in Surgery;2024-05-27

3. Immunosuppression, Compliance, and Tolerance After Orthotopic Liver Transplantation: State of the Art;Experimental and Clinical Transplantation;2022-03

4. Randomized trial of steroid free immunosuppression with basiliximab induction in adult live donor liver transplantation (LDLT);HPB;2021-05

5. Long‐term survival of full‐thickness corneal xenografts from α1,3‐galactosyltransferase gene‐knockout miniature pigs in non‐human primates;Xenotransplantation;2019-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3